Machine-Learning-Based Clinical Biomarker Using Cell-Free DNA for Hepatocellular Carcinoma (HCC)

SIMPLE SUMMARY: Circulating cell-free DNA (cfDNA) has attracted a great deal of scientific interest as a predictive biomarker for the diagnosis and prognosis of hepatocellular carcinoma (HCC). HCC result in high mortality due to the absence of blood biomarkers for early diagnosis and prognosis. We e...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Taehee, Rawding, Piper A., Bu, Jiyoon, Hyun, Sunghee, Rou, Woosun, Jeon, Hongjae, Kim, Seokhyun, Lee, Byungseok, Kubiatowicz, Luke J., Kim, Dawon, Hong, Seungpyo, Eun, Hyuksoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103537/
https://www.ncbi.nlm.nih.gov/pubmed/35565192
http://dx.doi.org/10.3390/cancers14092061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103537/
https://www.ncbi.nlm.nih.gov/pubmed/35565192
http://dx.doi.org/10.3390/cancers14092061

Ejemplares similares